コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ate the degree of pathology in patients with facioscapulohumeral muscular dystrophy.
2 on chromosome 4 that is partially deleted in facioscapulohumeral muscular dystrophy.
3 wn-regulation of ALP does not participate in facioscapulohumeral muscular dystrophy.
4 e 4q35 and was identified as a candidate for facioscapulohumeral muscular dystrophy.
5 muscles with iliopsoas sparing is common in facioscapulohumeral muscular dystrophy (67% of the patie
6 ations of chromatin structure: ICF syndrome, facioscapulohumeral muscular dystrophy and a case of alp
7 ular dystrophy: Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and myotonic dys
8 are consistent with a model that configures facioscapulohumeral muscular dystrophy as a "muscle-by-m
9 nvolvement of fibroadipogenic progenitors in facioscapulohumeral muscular dystrophy.Facioscapulohumer
10 scle MRI can be also used for distinguishing facioscapulohumeral muscular dystrophy from other myopat
35 ce places the subtelomeric defect underlying facioscapulohumeral muscular dystrophy (FSHD) much close
37 ons in SMCHD1 that have been associated with facioscapulohumeral muscular dystrophy (FSHD) type 2.
38 subtelomeric region of chromosome 4q causes facioscapulohumeral muscular dystrophy (FSHD) when occur
40 ubtelomeric region, 4q35.2, is implicated in facioscapulohumeral muscular dystrophy (FSHD), a dominan
42 ce best supports an epigenetic mechanism for facioscapulohumeral muscular dystrophy (FSHD), whereby d
48 beginning of this disease-associated array (facioscapulohumeral muscular dystrophy, FSHD) despite se
50 olemma of skeletal muscle from patients with facioscapulohumeral muscular dystrophy (FSHD1A) to learn
51 ted with the age-associated genetic disease, facioscapulohumeral muscular dystrophy (FSHD1A, MIM 1589
52 5 near the heterochromatic region mutated in facioscapulohumeral muscular dystrophy, indicating a pos
54 he validity of the human graft as a model of facioscapulohumeral muscular dystrophy is demonstrated i
55 dystrophy (DMD), Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, limb-girdle musc
57 most frequent are the dystrophinopathies and facioscapulohumeral muscular dystrophy making up 22.9% (
58 fficient, and use this finding to develop an facioscapulohumeral muscular dystrophy mouse model with
60 lated to be affected by mutations that cause facioscapulohumeral muscular dystrophy; thus, the charac
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。